George R. Marcellino

Who is George R. Marcellino?

Dr. George Marcellino, Vice President and Co-founder of OptiMedica, is widely

known in the medical community, bringing more than twenty-five years experience

in the medical device industry. He has coordinated a number of ophthalmic

research efforts in areas such as Selective Laser Trabeculoplasty (SLT) for the

treatment of Glaucoma, Photodynamic Therapy (PDT) for the treatment of Exudative

Age-related Macular Degeneration, and Selective Retinal Therapy.

Prior to joining OptiMedica, Dr. Marcellino was Senior Director of Research

at Lumenis. He previously directed the worldwide sales and marketing

organizations and headed the clinical research and development efforts at the

Coherent Medical Group. He managed a 100-person sales and marketing team and

helped establish many innovative products, including the Novus 2000

Photocoagulator, the Laser Indirect Ophthalmoscope, and Laserlink delivery

system. Dr. Marcellino has authored 14 peer-reviewed articles in scientific

journals, two textbook chapters, and is an inventor on four patents. He received

his B.S., M.S. and Ph. D. in Sensory Physiology and Psychophysics, from the City

University of New York.